Open AccessCOVID-19 outcomes in people with cystic fibrosis
Author(s) -
PierreRégis Burgel,
Christopher H. Goss
Publication year - 2021
Publication title -
current opinion in pulmonary medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.937
H-Index - 75
eISSN - 1531-6971
pISSN - 1070-5287
DOI - 10.1097/mcp.0000000000000823
Subject(s) - medicine , pandemic , cystic fibrosis , population , intensive care medicine , covid-19 , lung transplantation , vaccination , clinical trial , transplantation , pediatrics , immunology , disease , environmental health , infectious disease (medical specialty)
The COVID-19 global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a dramatic impact that is still ongoing around the world. Cystic fibrosis (CF) has been identified as a possible risk factor of poor outcome.